Eton Pharmaceuticals Inc — balance (NASDAQ:ETON) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 26.32 M27.46 M25.03 M31.74 M76.12 M92.11 M Total de pasivos 10.66 M9.84 M11.95 M16.26 M51.7 M65.96 M Capital total 15.66 M17.63 M13.08 M15.48 M24.43 M26.15 M Total de pasivos y patrimonio neto 26.32 M27.46 M25.03 M31.74 M76.12 M92.11 M Deuda total 6.63 M5.28 M5.57 M75 K29.99 M30.56 M Deuda neta -14.66 M-9.13 M-10.74 M-21.31 M15.06 M4.62 M

Noticias

Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating

Arcutis Biotherapeutics Shows Market Leadership With Jump To 82 RS Rating

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Dow Jones Futures: Trump's Iran Comments Spark Stock Market Rally; Micron, Nvidia, Palantir, Tesla Are Big Movers

Stock Market Today: Dow Up As These Leisure Plays Cruise Higher; Pharma Stock Clears Entry (Live Coverage)

H.C. Wainwright eleva el precio objetivo de Eton Pharmaceuticals

B.Riley eleva el precio objetivo de Eton Pharmaceuticals tras sólidos resultados del cuarto trimestre

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Informe de resultados: Eton Pharmaceuticals supera el BPA del cuarto trimestre de 2025, la acción sube

Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates

Eton Pharmaceuticals supera por 0,01$ las previsiones de BPA en el primer trimestre del año

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates